Document is current
Any future updates will be listed below
-
Authors
Rezola Artero, Mikel
Minery, Andrea
Revel, Margot
Armento, Angela
Jarboui, Mohamed-Ali https://orcid.org/0000-0002-5203-235X
Boudhabhay, Idris https://orcid.org/0000-0002-8045-1658
de Castro Deus, Marina
Zarantonello, Alessandra https://orcid.org/0000-0002-9769-2271
Fleury, Emma
Segarra, Lou
Redissi, Alaeddine
Merle, Nicolas S.
Dragon-Durey, Marie-Agnes https://orcid.org/0000-0002-5809-8122
Monnot, Catherine https://orcid.org/0000-0003-1334-7348
Sautes-Fridman, Catherine https://orcid.org/0000-0003-1735-8722
Dimitrov, Jordan D. https://orcid.org/0000-0001-8536-8995
Fridman, Wolf Herman https://orcid.org/0000-0002-1332-0973
Ueffing, Marius https://orcid.org/0000-0003-2209-2113
Roumenina, Lubka T. https://orcid.org/0000-0002-9940-0324
- License Information
-
More Information
Article History
Received: 12 April 2025
Accepted: 24 February 2026
First Online: 5 March 2026
Competing interests
: L.T.R. declares receiving consultancy or lecturing fees from CommitBio, Erasca, Omeros, Octapharma and Alexion, and research grants from Roche, CSL Behring, CommitBio and Novartis, unrelated to this project. LTR, MR, CSF and WHF are among the co-inventors of the patent application: EP21305187.3, 2021, US20240132974A1, 2024. The other authors declare no competing interests.
